You made me laugh. Do you really believe your own nonsense?
The results on colorectal should be fabulous. IMO, the real combination should be DCVax-L + poly-iclc + keytruda since the trial was started after the poly-iclc trial stopped enrollment in January 2015 and poly-iclc was included in the UK compassionate use program starting in January 2016. You don't know that colorectal cancer has the TAM immuno-suppressive characteristic, do you? Now you should know what is the real motive behind the fact Merck fronted $4.5b to Daiichi.